Piramal Pharma Ltd gets zero observations from USFDA for Riverview, Michigan facility

The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited's Riverview (Michigan, USA) facility from 31st October 2022 to 04th November, 2022.

The inspection was completed successfully with Zero Form - 483 observations.

The Company remains committed to maintain the highest standards of compliance.

Shares of Piramal Pharma Limited was last trading in BSE at Rs. 156.45 as compared to the previous close of Rs. 163.95. The total number of shares traded during the day was 880449 in over 9502 trades.

The stock hit an intraday high of Rs. 161.00 and intraday low of 152.85. The net turnover during the day was Rs. 138706341.00.

Source : Equity Bulls

Keywords

PiramalPharma PPLPHARMA INE0DK501011 Pharmaceuticals Inspection ZeroObservations Michigan USA Facility